During November–December 2021, we performed a SARS-CoV-2 seroprevalence survey in Central and Western Divisions of Fiji. A total of 539 participants 8–70 years of age were 95.5% (95% CI 93.4%–97.1%) seropositive, indicating high community levels of immunity. Seroprevalence studies can inform public health responses to emerging SARS-CoV-2 variants.
All Keywords
【저자키워드】 COVID-19, coronavirus disease, severe acute respiratory syndrome coronavirus 2, viruses, respiratory infections, zoonoses, antibodies, SARS-CoV-2, coronavirus, SARS, Seroepidemiologic studies, disease outbreak, Pacific islands, Fiji,
【저자키워드】 COVID-19, coronavirus disease, severe acute respiratory syndrome coronavirus 2, viruses, respiratory infections, zoonoses, antibodies, SARS-CoV-2, coronavirus, SARS, Seroepidemiologic studies, disease outbreak, Pacific islands, Fiji,